Vontobel Holding’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Sell
1,776
-641
-27% -$112K ﹤0.01% 972
2025
Q4
$411K Buy
2,417
+393
+19% +$60.3K ﹤0.01% 1059
2025
Q3
$267K Sell
2,024
-666
-25% -$79.9K ﹤0.01% 1139
2025
Q2
$285K Sell
2,690
-887
-25% -$96.4K ﹤0.01% 1064
2025
Q1
$444K Sell
3,577
-656
-15% -$85.6K ﹤0.01% 822
2024
Q4
$521K Sell
4,233
-939
-18% -$111K ﹤0.01% 777
2024
Q3
$576K Sell
5,172
-1,788
-26% -$196K ﹤0.01% 751
2024
Q2
$743K Buy
6,960
+699
+11% +$76.8K ﹤0.01% 659
2024
Q1
$754K Buy
6,261
+3,014
+93% +$369K 0.01% 663
2023
Q4
$399K Sell
3,247
-291
-8% -$36.3K ﹤0.01% 852
2023
Q3
$458K Buy
3,538
+281
+9% +$37.4K ﹤0.01% 794
2023
Q2
$404K Sell
3,257
-305
-9% -$41K ﹤0.01% 850
2023
Q1
$521K Sell
3,562
-54
-1% -$7.99K ﹤0.01% 766
2022
Q4
$567K Sell
3,616
-593
-14% -$86.9K 0.01% 723
2022
Q3
$561K Buy
4,209
+244
+6% +$37.1K 0.01% 682
2022
Q2
$620K Sell
3,965
-265
-6% -$40.8K 0.01% 659
2022
Q1
$666K Sell
4,230
-1,082
-20% -$157K 0.01% 718
2021
Q4
$681K Buy
5,312
+148
+3% +$19.4K 0.01% 735
2021
Q3
$673K Buy
5,164
+3,438
+199% +$519K 0.01% 708
2021
Q2
$309K Buy
+1,726
New +$299K ﹤0.01% 908

Other funds holding JAZZ

Vontobel Holding's JAZZ Position: Q1 2026 in Review

Vontobel Holding reduced its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q1 2026, selling an estimated $112K and leaving 1,776 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Vontobel Holding first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $754K in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Vontobel Holding held 1,776 shares of Jazz Pharmaceuticals worth $336K as of Q1 2026.
  • Vontobel Holding sold 641 Jazz Pharmaceuticals shares in Q1 2026, an estimated $112K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #972 holding.
  • Vontobel Holding first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Vontobel Holding's Jazz Pharmaceuticals position peaked at $754K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.